131 related articles for article (PubMed ID: 36473530)
21. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
22. HBx-elevated SIRT2 promotes HBV replication and hepatocarcinogenesis.
Cheng ST; Ren JH; Cai XF; Jiang H; Chen J
Biochem Biophys Res Commun; 2018 Feb; 496(3):904-910. PubMed ID: 29366781
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic circuit constituted by Ser31-HBx and Akt increases risks of chronic hepatitis and hepatocellular carcinoma.
Lee WP; Lan KH; Li CP; Chao Y; Lin HC; Lee SD
Biochim Biophys Acta; 2016 Apr; 1862(4):837-849. PubMed ID: 26791804
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein.
Liu H; Xu L; He H; Zhu Y; Liu J; Wang S; Chen L; Wu Q; Xu J; Gu J
Cancer Sci; 2012 Dec; 103(12):2072-81. PubMed ID: 22957763
[TBL] [Abstract][Full Text] [Related]
25. Tripartite Motif Containing 52 (TRIM52) Promotes Cell Proliferation in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Zhang Y; Wu SS; Chen XH; Tang ZH; Yu YS; Zang GQ
Med Sci Monit; 2017 Nov; 23():5202-5210. PubMed ID: 29089476
[TBL] [Abstract][Full Text] [Related]
26. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
[TBL] [Abstract][Full Text] [Related]
27. HBx promotes hepatocarcinogenesis by enhancing phosphorylation and blocking ubiquitinylation of UHRF2.
Cheng F; Qian G; Fang X; Sun J; Chen S; Chen R; Liu S; Li Z; Wu K; Jiang S; Chen Y; Tang N; Chen J; Duan C
Hepatol Int; 2021 Jun; 15(3):707-719. PubMed ID: 33876395
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.
Zhang T; Zhang J; Cui M; Liu F; You X; Du Y; Gao Y; Zhang S; Lu Z; Ye L; Zhang X
Neoplasia; 2013 Nov; 15(11):1282-91. PubMed ID: 24339740
[TBL] [Abstract][Full Text] [Related]
29. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.
Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
[TBL] [Abstract][Full Text] [Related]
30. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
[TBL] [Abstract][Full Text] [Related]
31. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
[TBL] [Abstract][Full Text] [Related]
32. Chromatin remodelling factor BAF155 protects hepatitis B virus X protein (HBx) from ubiquitin-independent proteasomal degradation.
Chen H; Zhang Y; Ye S; Wu Q; Lin Y; Sheng K; Chen W; Lin X; Lin X
Emerg Microbes Infect; 2019; 8(1):1393-1405. PubMed ID: 31533543
[TBL] [Abstract][Full Text] [Related]
33. Hepatocystin/80K-H inhibits replication of hepatitis B virus through interaction with HBx protein in hepatoma cell.
Shin GC; Ahn SH; Choi HS; Lim KH; Choi DY; Kim KP; Kim KH
Biochim Biophys Acta; 2013 Oct; 1832(10):1569-81. PubMed ID: 23644164
[TBL] [Abstract][Full Text] [Related]
34. Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein.
Arzumanyan A; Sambandam V; Clayton MM; Choi SS; Xie G; Diehl AM; Yu DY; Feitelson MA
Cancer Res; 2012 Nov; 72(22):5912-20. PubMed ID: 22986746
[TBL] [Abstract][Full Text] [Related]
35. Carboxyl-terminal truncated HBx contributes to invasion and metastasis via deregulating metastasis suppressors in hepatocellular carcinoma.
Li W; Li M; Liao D; Lu X; Gu X; Zhang Q; Zhang Z; Li H
Oncotarget; 2016 Aug; 7(34):55110-55127. PubMed ID: 27391153
[TBL] [Abstract][Full Text] [Related]
36. 14-3-3ζ binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells.
Tang Y; Zhang Y; Wang C; Sun Z; Li L; Dong J; Zhou W
Cancer Med; 2018 Nov; 7(11):5543-5553. PubMed ID: 30358169
[TBL] [Abstract][Full Text] [Related]
37. HBx-induced S100A9 in NF-κB dependent manner promotes growth and metastasis of hepatocellular carcinoma cells.
Duan L; Wu R; Zhang X; Wang D; You Y; Zhang Y; Zhou L; Chen W
Cell Death Dis; 2018 May; 9(6):629. PubMed ID: 29795379
[TBL] [Abstract][Full Text] [Related]
38. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
39. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
[TBL] [Abstract][Full Text] [Related]
40. Spatiotemporal modulation of SMAD4 by HBx is required for cellular proliferation in hepatitis B-related liver cancer.
Chaomin W; Wenhao N; Jialei H; Ting Z; Honglei F; Zhuang H; Yichao W; Changsen B; Yueguo L
Cell Oncol (Dordr); 2022 Aug; 45(4):573-589. PubMed ID: 35716259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
